240 related articles for article (PubMed ID: 37443284)
1. Transcription factor EGR2 controls homing and pathogenicity of T
Gao Y; Wang Y; Chauss D; Villarino AV; Link VM; Nagashima H; Spinner CA; Koparde VN; Bouladoux N; Abers MS; Break TJ; Chopp LB; Park JH; Zhu J; Wiest DL; Leonard WJ; Lionakis MS; O'Shea JJ; Afzali B; Belkaid Y; Lazarevic V
Nat Immunol; 2023 Aug; 24(8):1331-1344. PubMed ID: 37443284
[TBL] [Abstract][Full Text] [Related]
2. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
4. Th17 cell promotes apoptosis of IL-23R
Sonar SA; Meitei HT; Karmakar S; Mishra A; Inamdar S; Lenka N; Lal G
Clin Immunol; 2024 Feb; 259():109898. PubMed ID: 38185267
[TBL] [Abstract][Full Text] [Related]
5. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Kong W; Li H; Tuma RF; Ganea D
Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
[TBL] [Abstract][Full Text] [Related]
6. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
7. BTN2A2-Ig protein inhibits the differentiation of pathogenic Th17 cells and attenuates EAE in mice.
Huang Y; Han F; Li J; Li Y; Gao J; Lai L; Luo P; Su M; Hu R
Immunol Lett; 2023 Aug; 260():58-67. PubMed ID: 37369312
[TBL] [Abstract][Full Text] [Related]
8. Integrin α3 promotes T
Park E; Barclay WE; Barrera A; Liao TC; Salzler HR; Reddy TE; Shinohara ML; Ciofani M
Sci Immunol; 2023 Oct; 8(88):eadg7597. PubMed ID: 37831759
[TBL] [Abstract][Full Text] [Related]
9. EGR2 drives T
Nat Immunol; 2023 Aug; 24(8):1230-1231. PubMed ID: 37474655
[No Abstract] [Full Text] [Related]
10. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
[TBL] [Abstract][Full Text] [Related]
11. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
12. Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.
Morianos I; Trochoutsou AI; Papadopoulou G; Semitekolou M; Banos A; Konstantopoulos D; Manousopoulou A; Kapasa M; Wei P; Lomenick B; Belaidi E; Kalamatas T; Karageorgiou K; Doskas T; Sallusto F; Pan F; Garbis SD; Quintana FJ; Xanthou G
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12269-12280. PubMed ID: 32409602
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic STAT4 Expression Controls Effector CD4 T Cell Migration and Th17 Pathogenicity.
Buzzelli AA; McWilliams IL; Shin B; Bryars MT; Harrington LE
J Immunol; 2023 Jun; 210(11):1667-1676. PubMed ID: 37093664
[TBL] [Abstract][Full Text] [Related]
15. Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation.
Quinn JL; Kumar G; Agasing A; Ko RM; Axtell RC
Front Immunol; 2018; 9():382. PubMed ID: 29535739
[TBL] [Abstract][Full Text] [Related]
16. Anlotinib attenuates experimental autoimmune encephalomyelitis mice model of multiple sclerosis
Zhu H; Li G; Yin J; Zhang H; Da Y; Li L
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):594-602. PubMed ID: 35638564
[TBL] [Abstract][Full Text] [Related]
17. TLR4-RelA-miR-30a signal pathway regulates Th17 differentiation during experimental autoimmune encephalomyelitis development.
Qu X; Han J; Zhang Y; Wang X; Fan H; Hua F; Yao R
J Neuroinflammation; 2019 Sep; 16(1):183. PubMed ID: 31561751
[TBL] [Abstract][Full Text] [Related]
18. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
[TBL] [Abstract][Full Text] [Related]
19. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Glatigny S; Duhen R; Arbelaez C; Kumari S; Bettelli E
Sci Rep; 2015 Jan; 5():7834. PubMed ID: 25592296
[TBL] [Abstract][Full Text] [Related]
20. T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
O'Connor RA; Cambrook H; Huettner K; Anderton SM
Eur J Immunol; 2013 Nov; 43(11):2818-23. PubMed ID: 23878019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
